The prognostic value of neurofilament light chain in serum
Research output: Contribution to journal › Comment/debate › Research › peer-review
Standard
The prognostic value of neurofilament light chain in serum. / Sellebjerg, Finn; Magyari, Melinda.
In: The Lancet Neurology, Vol. 21, No. 3, 2022, p. 207-208.Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The prognostic value of neurofilament light chain in serum
AU - Sellebjerg, Finn
AU - Magyari, Melinda
N1 - Funding Information: FS declares grants from Biogen, Merck, Novartis, Roche, and Sanofi Genzyme; consulting fees from Novartis; speaking fees from Biogen, Bristol Myers Squibb, Merck, Novartis, Roche, and Sanofi Genzyme; travel support from Biogen and Roche; and fees for participating on a Data Safety Monitoring Board from Alexion, Biogen, Bristol Myers Squibb, Merck, Novartis, Roche, and Sanofi Genzyme. MM declares grants from Biogen Idec, Merck, Danish Multiple Sclerosis Society, Roche, Novartis, and Sanofi; speaking fees from Novartis, Bristol Myers Squibb, Roche, Biogen, and Merck; and travel support from Sanofi.
PY - 2022
Y1 - 2022
U2 - 10.1016/S1474-4422(22)00034-5
DO - 10.1016/S1474-4422(22)00034-5
M3 - Comment/debate
C2 - 35182499
AN - SCOPUS:85124630567
VL - 21
SP - 207
EP - 208
JO - The Lancet Neurology
JF - The Lancet Neurology
SN - 1474-4422
IS - 3
ER -
ID: 299216528